Group 1 - The project aims to build a high-quality, standardized data platform for the entire cycle of gastrointestinal tumor diagnosis and treatment, developing an AI-assisted diagnostic system to improve early detection rates and treatment precision in China [2][3] - The initiative is part of a national mechanism to accelerate key core technology breakthroughs and promote the transformation of scientific achievements in the healthcare sector [3] - The project is led by a core clinical and research team from Tongji Hospital, supported by Yidu Technology, focusing on integrating multimodal data to enhance AI-driven diagnostic processes [3][4] Group 2 - The technology core of the project is based on "multimodal" and "standardization," aiming to create a comprehensive, high-quality gastrointestinal tumor data asset library that enhances the efficiency of AI product development [4] - The collaboration plans to gather and govern tens of thousands of high-quality case data, developing AI algorithms for early screening, precise classification, efficacy prediction, and recurrence risk assessment [4] - The project will also establish clinical application guidelines and industry standards for AI in gastrointestinal tumor diagnosis and treatment, fostering the development of professionals with both clinical and data science expertise [4][5] Group 3 - Yidu Technology has extensive experience in data governance and multimodal analysis, having served 127 well-known medical institutions and processed nearly 7 billion authorized medical records by September 30, 2025 [5] - The collaboration represents a practical application of an innovative model driven by clinical needs and AI development, aiming to enhance the overall diagnostic level for gastrointestinal tumors in China [5] - The project is expected to contribute to the "Healthy China 2030" initiative by establishing data governance standards and AI development pathways that can be replicated in other major disease areas [5]
成功“揭榜”国家级任务！医渡科技(02158)携手同济医院攻关胃肠肿瘤AI诊疗